Orchestra Bio
A San Francisco startup that builds AI agents and an intelligent management platform for biotech and pharma R&D teams, helping them plan programs and run drug development operations.
Its agents track studies, spending and schedules, and help resolve clinical trial scheduling conflicts. Channel Insider names Ashoka Rajendra as its founder and CEO, and says it had reportedly raised about $20 million as of 2025 from Andreessen Horowitz, Atria and 8VC, per TechCrunch. Kingy AI states it was founded in 2022, and its own farewell post says it was started four years before October 2026.
On 20 October 2026 OpenAI announced it would acquire Orchestra Bio and fold its team and technology into Rosalind, OpenAI's suite of life-sciences models and tools. Financial terms were not disclosed and no timeline has been given for when the agents will reach OpenAI products. Orchestra's own site says it is joining OpenAI.
SourceSocial platforms
External Links · 4